The 2026 Global Delphi Consensus on Acne and the Microbiome will not change acne care yet because it offers expert agreement, not proven new treatments. People with acne-prone skin should continue proven routines while microbiome options are still being tested. A Delphi consensus is a structured survey where experts vote toward agreement. Here the topic is the microbiome, the community of bacteria and other microbes living on skin and in the gut.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the international panel agreed
- Why agreement is not proof
- What standard acne care uses now
- What to do if your skin is acne-prone
What the international panel agreed
The paper titled A Global Delphi Consensus on Acne and the Microbiome was published in Pharmaceuticals in 2026 as volume 19, article 697, as described by MDPI Pharmaceuticals in the consensus report. The panel brought together international experts on prevention and treatment strategies. Enthusiasm was strong.
The consensus document reports 100% agreement that microbiome-targeted treatments should be adopted for acne management, according to MDPI Pharmaceuticals in the full consensus PDF. The panel also reached 89% agreement that the microbiome influences severity, the gut-skin axis affects acne, and probiotics, prebiotics, and postbiotics belong in therapy. Probiotics are live helpful microbes. Prebiotics feed them, and postbiotics are useful compounds they make.
Why agreement is not proof
The same consensus paper states its views reflect expert agreement where evidence remains mixed and changing, according to MDPI Pharmaceuticals. That means the panel is pointing to a promising direction, not issuing final treatment rules.
This limit is common for Delphi work. JAMA Dermatology notes such recommendations generally reflect structured expert opinion informed by experience and available evidence rather than prospective validation, as described in the dermatology methods discussion. For readers, the distinction matters because a treatment still needs patient trials before it becomes standard care.
What standard acne care uses now
Current U.S. care under the 2024 American Academy of Dermatology guideline still centers on benzoyl peroxide, topical retinoids, topical or oral antibiotics in combinations, and isotretinoin for severe acne, as summarized by Medscape in the AAD guideline summary. These drugs reduce bacteria, unclog pores, calm inflammation, or lower oil.
A common routine pairs a retinoid at night with benzoyl peroxide in the morning. Antibiotics are usually combined with benzoyl peroxide to limit resistance. Severe, scarring, or treatment-resistant acne may lead a dermatologist to discuss isotretinoin.
What to do if your skin is acne-prone
Keep using the retinoid or benzoyl peroxide routine that controls your breakouts. Do not stop it to try a commercial probiotic gummy, drink, or supplement.
No probiotic is FDA-approved to treat skin conditions. Ask your dermatologist before adding any gut-skin product, especially if you use antibiotics, isotretinoin, or have a sensitive-skin condition. Bring a simple list to that visit:.
- current cleanser, retinoid, benzoyl peroxide, and moisturizer
- breakouts, dryness, burning, or missed doses
- any probiotic or supplement you want to try
You Might Also Like
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Why the Findings May Not Change Acne Care Yet for People With Acne-Prone Skin
- Why the 2026 Probiotic and Secretome Paper Reports No Trial Results Yet: Why the Findings May Not Change Acne Care Yet for People With Acne-Prone Skin
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: Why the Findings May Not Change Acne Care Yet for People With Acne-Prone Skin